Who Exports Ketoconazole from India — 446 Suppliers Behind a $39.4M Market
India's ketoconazole export market is supplied by 446 active exporters who collectively shipped $39.4M across 4,053 shipments. KUSUM HEALTHCARE PRIVATE LIMITED leads with a 17.1% market share, followed by ENCUBE ETHICALS PRIVATE LIMITED and STRIDES PHARMA SCIENCE LIMITED. The top 5 suppliers together control 55.5% of total export value, reflecting a moderately competitive market structure.
Top Ketoconazole Exporters from India — Ranked by Export Value
KUSUM HEALTHCARE PRIVATE LIMITED is the leading ketoconazole exporter from India, holding a 17.1% share of the $39.4M market across 4,053 shipments from 446 exporters. The top 5 suppliers — KUSUM HEALTHCARE PRIVATE LIMITED, ENCUBE ETHICALS PRIVATE LIMITED, STRIDES PHARMA SCIENCE LIMITED, MICRO LABS LIMITED, MERCURY HEALTHCARE PRIVATE LIMITED — collectively control 55.5% of total export value, indicating a moderately concentrated market. Individual shares are: KUSUM HEALTHCARE PRIVATE LIMITED (17.1%), ENCUBE ETHICALS PRIVATE LIMITED (16.6%), STRIDES PHARMA SCIENCE LIMITED (15.1%), MICRO LABS LIMITED (3.4%), MERCURY HEALTHCARE PRIVATE LIMITED (3.3%).
Top Ketoconazole Exporters from India
Ranked by export value · 446 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | KUSUM HEALTHCARE PRIVATE LIMITED CANDIKET - 200DERMAZOLE SHAMPOO 100 ML(KETOCONAZOLE 2%DERMAZOLE SHAMPOO 50 ML (KETOCONAZOLE 2% | $6.8M | 14 | 17.1% |
| 2 | ENCUBE ETHICALS PRIVATE LIMITED KETOCONAZOLE TABS 200MG 9648 00 X 100 SKETOCONAZOLE TABS 200MG 16,128.00 X 100SKETOCONAZOLE TABS 200MG 12,960.00X 100'S | $6.5M | 1 | 16.6% |
| 3 | STRIDES PHARMA SCIENCE LIMITED KETOCONAZOLE TABS 200MG 9648 00 X 100 SKETOCONAZOLE TABS 200MG 16,128.00 X 100SKETOCONAZOLE TABS 200MG 12,960.00X 100'S | $6.0M | 2 | 15.1% |
| 4 | MICRO LABS LIMITED CANDIKET - 200PHYTORAL 200 ( (KETOCONAZOLE 200MG USP TPHYTORAL OINTMENT ( (KETOCONAZOLE OINTME | $1.3M | 10 | 3.4% |
| 5 | MERCURY HEALTHCARE PRIVATE LIMITED PHARMACEUTICAL PRODUCTS. KETOCONAZOLE TAAXORAL TABLETS KETOCONAZOLE TABLETS USPAXORAL TABLETS - KETOCONAZOLE TABLETS US | $1.3M | 2 | 3.3% |
| 6 | CAPLIN POINT LABORATORIES LIMITED KETOCONAZOLE TABLETS USP 200MGPHARMACEUTICAL FORMULATIONS KETOCONAZOLEKETOCONAZOLE 2% CREAM 30GM | $1.1M | 8 | 2.9% |
| 7 | OSAKA PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS. KETOCONAZOLE TAAXORAL TABLETS KETOCONAZOLE TABLETS USPAXORAL TABLETS - KETOCONAZOLE TABLETS US | $1.0M | 1 | 2.6% |
| 8 | TRIOPLUS PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS KETOCONAZOLE TABLETS USP 200MGKETOJOHN-GOLD SHAMPOO 100ML SHAMPOO)KETOCONAZOLE & ZPT SHAMPOO 100ML | $1.0M | 2 | 2.6% |
| 9 | GALENTIC PHARMA INDIA PVT LTD | $756.2K | 3 | 1.9% |
| 10 | CLAROID PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS. KETOCONAZOLE TAAXORAL TABLETS KETOCONAZOLE TABLETS USPAXORAL TABLETS - KETOCONAZOLE TABLETS US | $747.5K | 1 | 1.9% |
| 11 | MAAN PHARMACEUTICALS LTD CANDIKET - 200KETOCONAZOLE CREAM 2% W/W UNIT:3KETOMAC 1X10'S | $729.4K | 2 | 1.8% |
| 12 | S K AGE EXPORTS KETOCONAZOLE TABS 200MG 9648 00 X 100 SPHARMACEUTICAL PRODUCTS KETOCONAZOLE TABLETS USP 200MGPHARMACEUTICAL PRODUCTS. KETOCONAZOLE TA | $453.5K | 10 | 1.1% |
| 13 | GRACURE PHARMACEUTICALS LIMITED | $423.8K | 4 | 1.1% |
| 14 | KESAR PHARMA PRIVATE LIMITED PHARMACEUTICAL PRODUCTS. KETOCONAZOLE TAAXORAL TABLETS KETOCONAZOLE TABLETS USPAXORAL TABLETS - KETOCONAZOLE TABLETS US | $420.3K | 2 | 1.1% |
| 15 | CARIESCO EXPORTS PHARMACEUTICAL PRODUCTS. KETOCONAZOLE TAAXORAL TABLETS KETOCONAZOLE TABLETS USPAXORAL TABLETS - KETOCONAZOLE TABLETS US | $385.4K | 3 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ketoconazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| KUSUM HEALTHCARE PRIVATE LIMITED | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for non-sterile products including tablets and capsules. (uzph |
| ENCUBE ETHICALS PRIVATE LIMITED | Not Listed | Yes, as of May 4, 20 | No | Not verified | WHO-GMP certified for ointments. |
| STRIDES PHARMA SCIENCE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certified for manufacturing in Puducherry, India. (extranet.who.int) |
| MICRO LABS LIMITED | Not Listed | Yes, as of August 9, | No | Not verified | WHO-GMP certified for manufacturing in Goa, India. (extranet.who.int) |
| GRACURE PHARMACEUTICALS LIMITED | Not Listed | Yes, as of December | No | Not verified | WHO-GMP certified for manufacturing in Rajasthan, India. (verification.fda.gov.p |
TransData Nexus reviewed the regulatory standing of 5 leading Ketoconazole exporters from India. 0 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ketoconazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city's pharmaceutical sector is bolstered by a robust infrastructure and a skilled workforce, making it a prime location for API manufacturing. Companies in Hyderabad are well-positioned to supply high-quality ketoconazole APIs, ensuring a reliable source for formulation manufacturers.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts a significant number of manufacturing units dedicated to producing finished dosage forms, including tablets, creams, and shampoos containing ketoconazole. The presence of companies like Cadila Pharmaceuticals in Ahmedabad underscores the area's capacity for large-scale formulation production.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for Indian pharmaceuticals. With its proximity to major ports and well-established logistics networks, this cluster facilitates the efficient export of pharmaceutical products, including ketoconazole formulations, to international markets. The region's strategic location enhances India's position as a leading exporter of generic medicines.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, largely due to favorable tax incentives and supportive government policies. This area attracts numerous pharmaceutical companies specializing in various drug formulations, including antifungal agents like ketoconazole. The cost advantages offered by this region make it an attractive option for sourcing pharmaceutical products.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with manufacturers across different clusters to mitigate risks associated with regional disruptions.
- Assess Quality Certifications: Prioritize suppliers with WHO-GMP and USFDA certifications to ensure compliance with international quality standards.
- Evaluate Export Capabilities: Partner with companies in export-centric regions like Mumbai-Thane-Raigad to streamline logistics and reduce lead times.
- Leverage Cost Advantages: Consider sourcing from tax incentive zones such as Baddi-Nalagarh to benefit from cost efficiencies in production.
By strategically selecting suppliers from these key pharmaceutical clusters, companies can optimize their supply chain for ketoconazole products, ensuring quality, cost-effectiveness, and timely delivery.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ketoconazole exporters from India
Strides Pharma Science Limited — Strides reduces stake in Consumer Healthcare Business
In August 2022, Strides Pharma Science Limited reduced its voting rights in its Consumer Healthcare Business from 53.64% to 19%, ceding board representation and deconsolidating the business from its financials. - IMPACT: This strategic move allows Strides to focus more on its core pharmaceutical operations, potentially enhancing its Ketoconazole export capabilities.
Impact: This strategic move allows Strides to focus more on its core pharmaceutical operations, potentially enhancing its Ketoconazole export capabilities.
Strides Pharma Science Limited — Strides merges with Vivimed Life Sciences
On January 6, 2023, Strides Pharma Science Limited completed the merger with its wholly-owned subsidiary, Vivimed Life Sciences Private Limited, with an appointed date of April 1, 2021. - IMPACT: The merger is expected to streamline operations and may lead to increased production efficiency for Ketoconazole exports.
Impact: The merger is expected to streamline operations and may lead to increased production efficiency for Ketoconazole exports.
Strides Pharma Science Limited — Strides reduces stake in Universal Corporation Limited
Effective September 30, 2022, Strides reduced its equity shareholding in Universal Corporation Limited below majority and ceded control over the board in favor of other existing shareholders. - IMPACT: This adjustment allows Strides to reallocate resources, potentially bolstering its Ketoconazole export operations.
Impact: This adjustment allows Strides to reallocate resources, potentially bolstering its Ketoconazole export operations.
Common Questions — Ketoconazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ketoconazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, KUSUM HEALTHCARE PRIVATE LIMITED leads with 391 recorded shipments worth $6.8M. ENCUBE ETHICALS PRIVATE LIMITED (116 shipments) and STRIDES PHARMA SCIENCE LIMITED (28 shipments) are also established high-volume exporters.
Q How many ketoconazole manufacturers are there in India?
India has 446 active ketoconazole exporters with a combined export market of $39.4M across 4,053 shipments to 139 countries. The top 5 suppliers hold 55.5% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ketoconazole from India?
Average FOB unit price: $2.87 per unit, ranging from $0.00 to $190.13. Average shipment value: $9.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 446 verified Indian exporters of Ketoconazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,053 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 139 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,053 Verified Shipments
446 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists